264 related articles for article (PubMed ID: 23046320)
1. Lower limb multilevel treatment with drug-eluting balloons: 6-month results from the DEBELLUM randomized trial.
Fanelli F; Cannavale A; Boatta E; Corona M; Lucatelli P; Wlderk A; Cirelli C; Salvatori FM
J Endovasc Ther; 2012 Oct; 19(5):571-80. PubMed ID: 23046320
[TBL] [Abstract][Full Text] [Related]
2. The "DEBELLUM"--lower limb multilevel treatment with drug eluting balloon--randomized trial: 1-year results.
Fanelli F; Cannavale A; Corona M; Lucatelli P; Wlderk A; Salvatori FM
J Cardiovasc Surg (Torino); 2014 Apr; 55(2):207-16. PubMed ID: 24670828
[TBL] [Abstract][Full Text] [Related]
3. Drug-eluting balloon in peripheral intervention for the superficial femoral artery: the DEBATE-SFA randomized trial (drug eluting balloon in peripheral intervention for the superficial femoral artery).
Liistro F; Grotti S; Porto I; Angioli P; Ricci L; Ducci K; Falsini G; Ventoruzzo G; Turini F; Bellandi G; Bolognese L
JACC Cardiovasc Interv; 2013 Dec; 6(12):1295-302. PubMed ID: 24239203
[TBL] [Abstract][Full Text] [Related]
4. Paclitaxel-eluting balloon vs. standard angioplasty to reduce recurrent restenosis in diabetic patients with in-stent restenosis of the superficial femoral and proximal popliteal arteries: the DEBATE-ISR study.
Liistro F; Angioli P; Porto I; Ricci L; Ducci K; Grotti S; Falsini G; Ventoruzzo G; Turini F; Bellandi G; Bolognese L
J Endovasc Ther; 2014 Feb; 21(1):1-8. PubMed ID: 24502477
[TBL] [Abstract][Full Text] [Related]
5. The LEVANT I (Lutonix paclitaxel-coated balloon for the prevention of femoropopliteal restenosis) trial for femoropopliteal revascularization: first-in-human randomized trial of low-dose drug-coated balloon versus uncoated balloon angioplasty.
Scheinert D; Duda S; Zeller T; Krankenberg H; Ricke J; Bosiers M; Tepe G; Naisbitt S; Rosenfield K
JACC Cardiovasc Interv; 2014 Jan; 7(1):10-9. PubMed ID: 24456716
[TBL] [Abstract][Full Text] [Related]
6. Paclitaxel-coated balloons reduce restenosis after femoro-popliteal angioplasty: evidence from the randomized PACIFIER trial.
Werk M; Albrecht T; Meyer DR; Ahmed MN; Behne A; Dietz U; Eschenbach G; Hartmann H; Lange C; Schnorr B; Stiepani H; Zoccai GB; Hänninen EL
Circ Cardiovasc Interv; 2012 Dec; 5(6):831-40. PubMed ID: 23192918
[TBL] [Abstract][Full Text] [Related]
7. Drug-eluting balloon angioplasty versus uncoated balloon angioplasty for the treatment of in-stent restenosis of the femoropopliteal arteries.
Kayssi A; Al-Jundi W; Papia G; Kucey DS; Forbes T; Rajan DK; Neville R; Dueck AD
Cochrane Database Syst Rev; 2019 Jan; 1(1):CD012510. PubMed ID: 30684445
[TBL] [Abstract][Full Text] [Related]
8. Randomized trial of Legflow(®) paclitaxel eluting balloon and stenting versus standard percutaneous transluminal angioplasty and stenting for the treatment of intermediate and long lesions of the superficial femoral artery (RAPID trial): study protocol for a randomized controlled trial.
Karimi A; de Boer SW; van den Heuvel DA; Fioole B; Vroegindeweij D; Heyligers JM; Lohle PN; Elgersma O; Nolthenius RP; Vos JA; de Vries JP
Trials; 2013 Mar; 14():87. PubMed ID: 23537403
[TBL] [Abstract][Full Text] [Related]
9. Drug-eluting balloon angioplasty versus uncoated balloon angioplasty for peripheral arterial disease of the lower limbs.
Kayssi A; Al-Atassi T; Oreopoulos G; Roche-Nagle G; Tan KT; Rajan DK
Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD011319. PubMed ID: 27490003
[TBL] [Abstract][Full Text] [Related]
10. Paclitaxel-Eluting Balloon Versus Standard Balloon Angioplasty in In-Stent Restenosis of the Superficial Femoral and Proximal Popliteal Artery: 1-Year Results of the PACUBA Trial.
Kinstner CM; Lammer J; Willfort-Ehringer A; Matzek W; Gschwandtner M; Javor D; Funovics M; Schoder M; Koppensteiner R; Loewe C; Ristl R; Wolf F
JACC Cardiovasc Interv; 2016 Jul; 9(13):1386-92. PubMed ID: 27388828
[TBL] [Abstract][Full Text] [Related]
11. Randomized comparison of femoropopliteal artery drug-eluting balloons and drug-eluting stents (FOREST trial): Study protocol for a randomized controlled trial.
Jongsma H; van Mierlo-van den Broek P; Imani F; van den Heuvel D; de Vries JPM; Fioole B
J Vasc Surg; 2017 Oct; 66(4):1293-1298. PubMed ID: 28826727
[TBL] [Abstract][Full Text] [Related]
12. Paclitaxel-Eluting Balloon vs Standard Angioplasty to Reduce Restenosis in Diabetic Patients With In-Stent Restenosis of the Superficial Femoral and Proximal Popliteal Arteries: Three-Year Results of the DEBATE-ISR Study.
Grotti S; Liistro F; Angioli P; Ducci K; Falsini G; Porto I; Ricci L; Ventoruzzo G; Turini F; Bellandi G; Bolognese L
J Endovasc Ther; 2016 Feb; 23(1):52-7. PubMed ID: 26511896
[TBL] [Abstract][Full Text] [Related]
13. Acotec Drug-Coated Balloon Catheter: Randomized, Multicenter, Controlled Clinical Study in Femoropopliteal Arteries: Evidence From the AcoArt I Trial.
Jia X; Zhang J; Zhuang B; Fu W; Wu D; Wang F; Zhao Y; Guo P; Bi W; Wang S; Guo W
JACC Cardiovasc Interv; 2016 Sep; 9(18):1941-9. PubMed ID: 27659572
[TBL] [Abstract][Full Text] [Related]
14. Drug-eluting balloons for femoropopliteal lesions show better performance in de novo stenosis or occlusion than in restenosis.
Herten M; Torsello GB; Schönefeld E; Imm B; Osada N; Stahlhoff S
J Vasc Surg; 2015 Feb; 61(2):394-9. PubMed ID: 25307133
[TBL] [Abstract][Full Text] [Related]
15. Paclitaxel-coated balloon angioplasty versus drug-eluting stenting for the treatment of infrapopliteal long-segment arterial occlusive disease: the IDEAS randomized controlled trial.
Siablis D; Kitrou PM; Spiliopoulos S; Katsanos K; Karnabatidis D
JACC Cardiovasc Interv; 2014 Sep; 7(9):1048-56. PubMed ID: 25234679
[TBL] [Abstract][Full Text] [Related]
16. Paclitaxel-Coated Balloon in Infrapopliteal Arteries: 12-Month Results From the BIOLUX P-II Randomized Trial (BIOTRONIK'S-First in Man study of the Passeo-18 LUX drug releasing PTA Balloon Catheter vs. the uncoated Passeo-18 PTA balloon catheter in subjects requiring revascularization of infrapopliteal arteries).
Zeller T; Beschorner U; Pilger E; Bosiers M; Deloose K; Peeters P; Scheinert D; Schulte KL; Rastan A; Brodmann M
JACC Cardiovasc Interv; 2015 Oct; 8(12):1614-22. PubMed ID: 26493253
[TBL] [Abstract][Full Text] [Related]
17. 1-Year Results of Paclitaxel-Coated Balloons for Long Femoropopliteal Artery Disease: Evidence From the SFA-Long Study.
Micari A; Vadalà G; Castriota F; Liso A; Grattoni C; Russo P; Marchese A; Pantaleo P; Roscitano G; Cesana BM; Cremonesi A
JACC Cardiovasc Interv; 2016 May; 9(9):950-6. PubMed ID: 27151609
[TBL] [Abstract][Full Text] [Related]
18. One-Year Clinical Outcomes of the Legflow Drug-Coated Balloon for the Treatment of Femoropopliteal Occlusions Registry.
Stabile E; Gerardi D; Magliulo F; Zhelev D; Chervenkoff V; Taeymans K; Kotasov D; Goverde P; Giugliano G; Trimarco B; Esposito G
J Endovasc Ther; 2019 Feb; 26(1):26-30. PubMed ID: 30760132
[TBL] [Abstract][Full Text] [Related]
19. Comparison of drug-coated balloon angioplasty versus uncoated balloon angioplasty in treatment of total occlusions with severe femoropopliteal lesions: An additional analysis from the AcoArt I study.
Sun G; Liu J; Jia S; Zhang J; Zhuang B; Jia X; Fu W; Wu D; Wang F; Zhao Y; Guo P; Bi W; Wang S; Guo W;
Vascular; 2021 Jun; 29(3):340-349. PubMed ID: 32903168
[TBL] [Abstract][Full Text] [Related]
20. Primary everolimus-eluting stenting versus balloon angioplasty with bailout bare metal stenting of long infrapopliteal lesions for treatment of critical limb ischemia.
Karnabatidis D; Spiliopoulos S; Diamantopoulos A; Katsanos K; Kagadis GC; Kakkos S; Siablis D
J Endovasc Ther; 2011 Feb; 18(1):1-12. PubMed ID: 21314342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
